Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors

Raptor Pharmaceutical Corp. (RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors, effective January 1, 2015. As previously disclosed, they will be joining Julie Anne Smith, President and CEO-Designate as she succeeds Christopher Starr, Ph.D., as Chief Executive Officer and joins the Board effective January 1, 2015.

Read full article: Yahoo Finance, December 18, 2014